Healthcare e-prescription continues to be delayed

| Source: dpa-AFX | Reading time about 1 min.

read text

BERLIN (dpa-AFX) – According to a press report, the planned electronic prescription in the healthcare sector is in danger of being delayed further. A decision on the nationwide introduction of the so-called e-prescription was again postponed, the specialist magazine “Apotheke Adhoc” reported on Tuesday, citing shareholders of the semi-public company Gematik, which is responsible for implementing the telematics infrastructure. At the shareholders’ meeting on Monday, there was still no resolution, according to the magazine, scheduling reasons were given as the reason. Gematik itself explained to the industry medium that no decisions of broader public interest were made at the non-public meeting.

The e-prescription is particularly important for online pharmacies. So far, customers have had to submit paper prescriptions for prescription drugs. The companies shop pharmacy -5,05% Europe and the Zur Rose subsidiary DocMorris are hoping for strong growth in this area once the e-prescription has been launched on a large scale. Shares in Shop Apotheke and Zur Rose -7,92% in Zurich lost 14 percent on Tuesday.

A test phase for the e-prescription is currently running. Federal Health Minister Karl Lauterbach (SPD) recently assumed that the 30,000 prescription mark would be reached in this test phase by the summer./men/jcf/stk

Source: dpa-AFX


, , , , , , , , , , ,

Source link

Healthy breakfast: delicious oatmeal muffins without sugar
Previous Filming has begun - new additions to the cast
Next "Those who don't invest in SILVER can only look at prices"